跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ORCIGESIC CAPSULE - HSA Drug Approval Details
Approvals
/
HSA
/
ORCIGESIC CAPSULE
Approved
THERAPEUTIC
ORCIGESIC CAPSULE
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Jul 10, 1992
Approval ID
dc0ec09878849edf
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
dc0ec09878849edf
Drug Name
ORCIGESIC CAPSULE
Product Name
ORCIGESIC CAPSULE
Approval Number
SIN07108P
Approval Date
1992-07-10
Registrant
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence Holder
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
M01AG01
Atc Item Name
mefenamic acid
Pharma Manufacturer Name
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
ORPHENADRINE CITRATE
35 mg
MEFENAMIC ACID
250 mg
MEFENAMIC ACID
250 MG
ORPHENADRINE CITRATE
35 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jul 10, 1992
Approval ID
dc0ec09878849edf
Type
Therapeutic
Back to HSA Approvals